JAK2 INHIBITORS AND THEIR APPLICATION FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND MALIGNANT TUMOR

摘要

The present invention relates to compounds of the formula I and their pharmaceutically acceptable salts. The compounds of formula I inhibit the tyrosine kinase activity of JAK2, which makes them applicable as antiproliferative agents for the treatment of malignant tumors and other diseases.